Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ancrod in Acute Ischemic Stroke (ESTAT)
NCT00343174Phase 3Completed
- Sponsor
- Heidelberg University
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of ancrod in ischemic stroke, sponsored by Heidelberg University. Status: completed.
02
Drugs
ancrod
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00343174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343174.